Feb. 27, 2014
/PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that
William S. Marth
, President and Chief Executive Officer at AMRI, will present at Barclays Global Healthcare Conference on
Wednesday, March 12, 2014
2:00 p.m. ET
A webcast of the presentation can be accessed at the Investor Relations' section of
, or at the following URL:
The webcast will be archived for 90 days following the live presentation.
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services. For over 22 years, AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in
the United States
now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For more information about AMRI, please visit our website at
or follow us on Twitter (@amriglobal).